VALIDATE-BSI 2019 Posters

VALIDATE-BSI 2019 Conference - Posters


Kiran Afshan

Asst Prof Kiran Afshan

Quaid-i-Azam University, Pakistan

Cutaneous Leishmaniasis in Khyber Pakhtunkhwa, Pakistan (abstract)


Anthony Afum-Adjei Awuah

Dr Anthony Afum-Adjei Awuah

Kumasi Centre for Collaborative Research (KCCR), Ghana

Why fix when you can prevent; towards TB Vaccines Research in Ghana (abstract)


Federico Carlos Blanco

Dr Federico Carlos Blanco

National Institute of Agricultural Technology (INTA), Argentina

The isolate Mb04-303 induce a proinflammatory innate immune profile and is a potential candidate for an attenuated mutant vaccine against bovine tuberculosis (abstract)


Justice Boakye-Appiah

Dr Justice Boakye-Appiah

St George's University of London, UK

Mycolactone based vaccine against Buruli ulcer disease (Section 3 talk; abstract)


Mary Burtnick

Assoc Prof Mary Burtnick

University of Nevada, Reno, USA

Optimization of melioidosis subunit vaccines using Burkholderia thailandensis E555 (abstract)


Panjaporn Chaichana

Dr Panjaporn Chaichana

MORU, Thailand

Identification of protective antibody profiles for vaccine development against melioidosis (abstract)


Narisara Chantratita

Assoc Prof Narisara Chantratita

Mahidol University, Thailand

Risk of Burkholderia pseudomallei infection, host immune response and biomarkers for melioidosis (abstract)


Myron Christodoulides

Prof Myron Christodoulides

University of Southampton, UK

Protective efficacy of conserved Leishmania hypothetical proteins against visceral leishmaniasis (VALIDATE-funded pump-priming project; abstract)


Fatoumatta Darboe

Dr Fatoumatta Darboe

MRC Unit at LSHTM, The Gambia

TB biomarkers: Diagnosis, prognosis and treatment response monitoring (Session 2 talk; abstract)


Chidchamai Kewcharoenwong

Dr Chidchamai Kewcharoenwong

Khon Kaen University, Thailand

Glibenclamide alters cytokine production of primary human monocytes from diabetic individuals against Mycobacterium tuberculosis infection (Session 1 talk; abstract)


Barbara Kronsteiner-Dobramysl

Dr Barbara Kronsteiner-Dobramysl

University of Oxford, UK

Metabolic reprogramming of skin microenvironment for improved BCG vaccine efficacy (VALIDATE funded pump-priming project; abstract)


Barbara Kronsteiner-Dobramysl

Dr Barbara Kronsteiner-Dobramysl

University of Oxford, UK

Diabetes alters cellular metabolism of T cells: implications for vaccine development (Session 1 talk; abstract)


Ganjana Lertmemongkolchai

Asst Prof Ganjana Lertmemongkolchai

Khon Kaen University, Thailand

Metformin-induced suppression of IFN-α expression via mTORC1 signalling following seasonal vaccination is associated with impaired antibody responses in diabetes mellitus (abstract)


Isadora Lima

Dr Isadora Lima


Canine visceral leishmaniasis: the role of tissue-specific immunity in the progression of disease (Session 1 talk; abstract)


Tufária Mussá

Asst Prof Tufária Mussá

Eduardo Mondlane University, Mozambique

The fusion protein Ag85B-Acr-HBHA (FPI) elicits IFN-γ, IL-2 and TNF-α in conventional T cells of Tuberculosis contacts with latent infection over time (Session 2 talk; abstract)


Rachel Okojie

Dr Rachel Okojie

University of Benin, Nigeria

Comparative study of the immunological and haematological parameters among tuberculosis naive and treated patients in Central Hospital, Benin City, Nigeria (abstract)


Mohamed Osman

Dr Mohamed Osman

University of York, UK

Identification of Leishmania donovani and Mycobacterium tuberculosis- derived proteins on the surface of infected macrophages that are associated with ADCC induction (VALIDATE funded pump-priming project; abstract)


Olayinka Osuolale

Dr Olayinka Osuolale

Elizade University, Nigeria

Leishmaniasis in patients attending a medical health center in the rural community of Ilara-Mokin, Ondo State, Nigeria (abstract)


Hannah Painter

Hannah Painter


Development of an ex vivo mycobacterial growth inhibition assay using murine lung cells for tuberculosis vaccine testing (Session 2 talk; abstract)


Deepa Paliwal

Dr Deepa Paliwal

University of Reading, UK

Progress in reverse vaccinology approach for bovine TB (Session 3 talk; abstract)


Vijay Prajapati

Asst Prof Vijay Kumar Prajapati

Central University of Rajasthan, India

Evaluation of immunogenicity of the engineered multi-epitope subunit vaccine against visceral leishmaniasis infection (abstract)


Eduardo Milton Ramos Sanchez

Dr Eduardo Ramos Sanchez

University of São Paulo, Brazil

Altered expression of microRNAs in infections with cutaneous and visceral strains of Leishmania (Session 2 talk; abstract)


Lok Bahadur Shrestha

Dr Lok Bahadur Shrestha

BP Koirala Institute of Health Sciences, Nepal

Emerging Clinical Microbiologist looking for research opportunity in TB Vaccinology (abstract)


Lisa Stockdale

Dr Lisa Stockdale

University of Oxford, UK

Cytomegalovirus as a correlate of risk for TB? (Session 1 talk; abstract)



Dr Suwarti

Eijkman Oxford Clinical Research Unit (EOCRU), Indonesia

Intranasal boosting regimen of Human Parainfluenza Virus Type 2-Ag85B vaccines induces superior CD4 immune response against Mycobacterium tuberculosis (abstract)


Rachel Tanner

Dr Rachel Tanner

University of Oxford, UK

Characterising the BCG-induced antibody response to inform the design of improved vaccines against M.tuberculosis, M.leprae and M.bovis (VALIDATE Fellowship; abstract)


Julen Tomás Cortázar

Dr Julen Tomás Cortázar

University College Dublin, Ireland

Elucidating the mechanisms of protection of the Burkholderia pseudomallei antigen, BpOmpW (abstract)


Chathika Weerasuriya

Chathika Weersuriya


Mathematical modelling of the epidemiological impact, cost-effectiveness and budget impact of novel tuberculosis vaccines on multi-drug resistant tuberculosis (abstract)